Exercise treatment to counteract protein wasting of chronic diseases
- PMID: 12496685
- DOI: 10.1097/00075197-200301000-00013
Exercise treatment to counteract protein wasting of chronic diseases
Abstract
Purpose of review: The objective is to summarize the findings from recent (June 2001-2002) studies that have examined the potential benefits of exercise training for the treatment of wasting associated with sarcopenia, cancer, chronic renal insufficiency, rheumatoid arthritis, osteoarthritis and HIV. In many clinical conditions, protein wasting and unintentional weight loss are predictors of morbidity and mortality. The pathogenesis of protein wasting in these conditions can be different, but the fundamental mechanism is an imbalance between muscle protein synthetic and proteolytic processes. The muscle proteins most affected and the precise alterations in their synthetic and proteolytic rates that occur in each cachectic condition are still under investigation.
Recent findings: Regular exercise, or sometimes just a modest increase in physical activity, can mitigate muscle protein wasting. Aerobic exercise training primarily alters mitochondrial and cytosolic proteins (enzyme activities), while progressive resistance exercise training predominantly increases contractile protein mass. Previous studies indicate that resistance exercise acutely increases the muscle protein synthetic rate more than muscle proteolysis such that the muscle amino acid balance is increased for up to 2 days after exercise. Progressive resistance exercise training increases muscle protein synthesis and muscle mass, but attenuates the increment in proteolysis that results from a single bout of resistance exercise. The cellular mechanisms that produce these adaptations are not entirely clear.
Summary: In general, patients with wasting conditions who can and will comply with a proper exercise program gain muscle protein mass, strength and endurance, and, in some cases, are more capable of performing the activities of daily living.
Similar articles
-
The biological mechanisms of cancer-related skeletal muscle wasting: the role of progressive resistance exercise.Biol Res Nurs. 2008 Jul;10(1):7-20. doi: 10.1177/1099800408317345. Biol Res Nurs. 2008. PMID: 18705151 Review.
-
Resistance exercise and appropriate nutrition to counteract muscle wasting and promote muscle hypertrophy.Curr Opin Clin Nutr Metab Care. 2010 Nov;13(6):630-4. doi: 10.1097/MCO.0b013e32833f1ae5. Curr Opin Clin Nutr Metab Care. 2010. PMID: 20829685 Review.
-
Exercise, aging, and muscle protein metabolism.J Gerontol A Biol Sci Med Sci. 2003 Oct;58(10):M918-22. doi: 10.1093/gerona/58.10.m918. J Gerontol A Biol Sci Med Sci. 2003. PMID: 14570859 Review.
-
Combined Exercise Training Positively Affects Muscle Wasting in Tumor-Bearing Mice.Med Sci Sports Exerc. 2019 Jul;51(7):1387-1395. doi: 10.1249/MSS.0000000000001916. Med Sci Sports Exerc. 2019. PMID: 30724848
-
Resistance exercise and nutrition to counteract muscle wasting.Appl Physiol Nutr Metab. 2009 Oct;34(5):817-28. doi: 10.1139/H09-093. Appl Physiol Nutr Metab. 2009. PMID: 19935843 Review.
Cited by
-
A meta-analysis of exercise interventions among people treated for cancer.Support Care Cancer. 2006 Jul;14(7):699-712. doi: 10.1007/s00520-005-0905-5. Epub 2006 Jan 31. Support Care Cancer. 2006. PMID: 16447036
-
Fatty Acid Profile and Antioxidant Status Fingerprint in Sarcopenic Elderly Patients: Role of Diet and Exercise.Nutrients. 2019 Oct 24;11(11):2569. doi: 10.3390/nu11112569. Nutrients. 2019. PMID: 31653011 Free PMC article. Clinical Trial.
-
The role and regulation of MAFbx/atrogin-1 and MuRF1 in skeletal muscle atrophy.Pflugers Arch. 2011 Mar;461(3):325-35. doi: 10.1007/s00424-010-0919-9. Epub 2011 Jan 11. Pflugers Arch. 2011. PMID: 21221630 Review.
-
The ERG1A K+ Channel Is More Abundant in Rectus abdominis Muscle from Cancer Patients Than that from Healthy Humans.Diagnostics (Basel). 2021 Oct 12;11(10):1879. doi: 10.3390/diagnostics11101879. Diagnostics (Basel). 2021. PMID: 34679577 Free PMC article.
-
Update on the Etiology, Assessment, and Management of COPD Cachexia: Considerations for the Clinician.Int J Chron Obstruct Pulmon Dis. 2022 Nov 18;17:2957-2976. doi: 10.2147/COPD.S334228. eCollection 2022. Int J Chron Obstruct Pulmon Dis. 2022. PMID: 36425061 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials